Joseph Ciaffoni - Feb 10, 2022 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Signature
/s/ Colleen Tupper as Attorney-In-Fact For Joseph Ciaffoni
Stock symbol
COLL
Transactions as of
Feb 10, 2022
Transactions value $
-$934,337
Form type
4
Date filed
2/14/2022, 05:37 PM
Previous filing
Jan 5, 2022
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Award $0 +125K +47.37% $0.00 389K Feb 10, 2022 Direct F1
transaction COLL Common Stock Award +65K +16.72% 454K Feb 10, 2022 Direct F2
transaction COLL Common Stock Tax liability -$426K -24.2K -5.32% $17.63 430K Feb 10, 2022 Direct F3
transaction COLL Common Stock Tax liability -$509K -28.8K -6.71% $17.63 401K Feb 10, 2022 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.
F2 On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 65,034 performance share units granted in the issuer's three prior fiscal years.
F3 Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
F4 Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.